复星国际：拟2.94亿美元出售附属公司Gland Pharma Limited部分股份

南方财经网09-06 19:56

南财智讯9月6日电，复星国际（00656.HK）公告：于2026年9月4日（印度时间），公司间接附属公司复星医药新加坡公司通过大宗交易及集中竞价方式，出售共计989.7万股目标公司GlandPharmaLimited（股份代号：GLAND）股份，约占其总股本的6.00%，交易总代价约为2.94亿美元（含交易成本）。交易完成后，本集团对目标公司的持股比例由51.76%降至45.76%，目标公司仍为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2665362883?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-06 19:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2665362883","market":"us","top_or_hot":-1,"title":"复星国际：拟2.94亿美元出售附属公司Gland Pharma Limited部分股份","media":"南方财经网","content":"<div>\n<p>南财智讯9月6日电，复星国际（00656.HK）公告：于2026年9月4日（印度时间），公司间接附属公司复星医药新加坡公司通过大宗交易及集中竞价方式，出售共计989.7万股目标公司GlandPharmaLimited（股份代号：GLAND）股份，约占其总股本的6.00%，交易总代价约为2.94亿美元（含交易成本）。交易完成后，本集团对目标公司的持股比例由51.76%降至45.76%，目标公司仍为...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202609063866122193.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星国际：拟2.94亿美元出售附属公司Gland Pharma Limited部分股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星国际：拟2.94亿美元出售附属公司Gland Pharma Limited部分股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-09-06 19:56 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202609063866122193.html><strong>南方财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>南财智讯9月6日电，复星国际（00656.HK）公告：于2026年9月4日（印度时间），公司间接附属公司复星医药新加坡公司通过大宗交易及集中竞价方式，出售共计989.7万股目标公司GlandPharmaLimited（股份代号：GLAND）股份，约占其总股本的6.00%，交易总代价约为2.94亿美元（含交易成本）。交易完成后，本集团对目标公司的持股比例由51.76%降至45.76%，目标公司仍为...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202609063866122193.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1230","symbol_name":"工业集团企业","start_time":0,"source_url":"http://finance.eastmoney.com/a/202609063866122193.html","article_id":"2665362883","we_media_id":null,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609063866122193.html","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2665362883","pubTimestamp":1788695760,"columns":[],"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"南财智讯9月6日电，复星国际（00656.HK）公告：于2026年9月4日（印度时间），公司间接附属公司复星医药新加坡公司通过大宗交易及集中竞价方式，出售共计989.7万股目标公司GlandPharmaLimited（股份代号：GLAND）股份，约占其总股本的6.00%，交易总代价约为2.94亿美元（含交易成本）。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1230":"工业集团企业","00656":"复星国际"},"translate_title":"Fosun International: Plans to sell a portion of its subsidiary Gland Pharma Limited for US$294 million.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00656":1.5},"content_text":"南财智讯9月6日电，复星国际（00656.HK）公告：于2026年9月4日（印度时间），公司间接附属公司复星医药新加坡公司通过大宗交易及集中竞价方式，出售共计989.7万股目标公司GlandPharmaLimited（股份代号：GLAND）股份，约占其总股本的6.00%，交易总代价约为2.94亿美元（含交易成本）。交易完成后，本集团对目标公司的持股比例由51.76%降至45.76%，目标公司仍为复星医药及本公司的附属公司。本次出售事项构成上市规则第14章项下的须予披露交易。所得款项将主要用于复星医药集团研发、股份回购及偿还带息债务等。（文章来源：南方财经网）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2665362883","isCrawlerRequest":true}